default author photo

SAbine Linn

Netherlands Cancer Institute

SCHOLARLY PAPERS

2

DOWNLOADS

76

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Clinical Characteristics and Prognostic Factors in Patients with Breast Cancer and Leptomeningeal Metastases from a Large Registry of Bmbc

Number of pages: 32 Posted: 10 Jan 2025
Elena Laakmann, Marcus Schmidt, Kristina Lübbe, Elisa Agostinetto, Mette van Ramshorst, Thomas Decker, Wolfram Malter, Francesco Schettini, Mário Fontes-Sousa, Carsten Denkert, Tanja Neunhöfer, Leonor Matos, SAbine Linn, Marc Thill, Rudolf Weide, Amanda Fitzpatrick, Marta Vaz Batista, Christoph Mundhenke, Tjoung-Won Park-Simon, Fanny le Du, Kerstin Riecke, Tanja N. Fehm, Isabell Witzel, Julia Rey, Valentina Nekljudova, Sibylle Loibl and Volkmar Müller
affiliation not provided to SSRN, University Medical Center Mainz - Department of Obstetrics and Gynecology, affiliation not provided to SSRN, Université Libre de Bruxelles (ULB) - Institute Jules Bordet, Netherlands Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Marburg - Institute for Pathology, affiliation not provided to SSRN, affiliation not provided to SSRN, Netherlands Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hannover Medical School, Centre Eugène Marquis, affiliation not provided to SSRN, University Hospital Düsseldorf - Department of Gynecology and Obstetrics, University Hospital Zurich, German Breast Group (GBG Forschungs GmbH) - German Breast Group, German Breast Group (GBG Forschungs GmbH), German Breast Group (GBG Forschungs GmbH) and University of Hamburg - University Medical Center Hamburg-Eppendorf
Downloads 49 (1,086,013)

Abstract:

Loading...

leptomeningeal metastasis, breast cancer, registry

2.

Intensified Alkylating Chemotherapy for Patients with Oligometastatic Breast Cancer Harboring Homologous Recombination Deficiency: Primary Outcomes from the Randomized Phase III Oligo Study

Number of pages: 29 Posted: 24 Jul 2024
Annemiek van Ommen-Nijhof, Tessa G. Steenbruggen, Terry G. Wiersma, Sara Balduzzi, Antonios Daletzakis, Marjo J. Holtkamp, Marjolein Delfos, Margaret Schot, Karin Beelen, Ester J.M. Siemerink, Joan Heijns, Ingrid A. Mandjes, Jelle Wesseling, Efraim H. Rosenberg, Marie-Jeanne T.F.D. Vrancken Peeters, SAbine Linn and Gabe Sonke
Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Rijnstate Hospital, Netherlands Cancer Institute, Amphia Hospital, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute and Netherlands Cancer Institute
Downloads 27 (1,372,601)

Abstract:

Loading...

oligometastatic breast cancer, homologous recombination deficiency, intensified alkylating chemotherapy, multimodality treatment